कृपया अन्य खोज का प्रयास करें
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David-Alexander C. Gros | 49 | 2020 | CEO & Non Independent Director |
Keith A. Katkin | 50 | 2015 | Independent Chairman of the Board |
Steven N. Perrin | 55 | 2020 | President, Chief Scientific Officer & Non Independent Director |
John S. McBride | 71 | 2017 | Independent Director |
Walter C. Ogier | 66 | 2020 | Independent Director |
Anne GM Schilder | - | 2018 | Member of Scientific Advisory Board |
Jan L. Hillson | 70 | 2021 | Independent Director |
Michael E. Pichichero | - | 2018 | Member of Scientific Advisory Board |
Paola Marchisio | - | 2018 | Member of Scientific Advisory Board |
June H. Lee | 57 | 2020 | Independent Director |
Tal Marom | - | 2018 | Member of Scientific Advisory Board |
Hamid Djalilian | - | 2018 | Member of Scientific Advisory Board |
Seth Pranksy | - | 2018 | Member of Scientific Advisory Board |
Allan Douglas Kirk | 62 | 2023 | Independent Director |
James A. Robinson | 54 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है